193 related articles for article (PubMed ID: 7918679)
21. Identification of a ferrochelatase mutation in a Chinese family with erythropoietic protoporphyria.
Kong XF; Ye J; Gao DY; Gong QM; Zhang DH; Lu ZM; Lu YM; Zhang XX
J Hepatol; 2008 Feb; 48(2):375-9. PubMed ID: 18160121
[TBL] [Abstract][Full Text] [Related]
22. Erythropoietic protoporphyria a clinical and molecular study from Lebanon: Ferrochelatase a potential tumor suppressor gene in colon cancer.
Kadara H; Nemer G; Safi R; Rebeiz N; Daou L; Delbani D; Btadini W; Abbas O; Tofaili M; Bitar F; Kibbi AG; Shimomura Y; Kurban M
Clin Genet; 2017 Nov; 92(5):495-502. PubMed ID: 28075030
[TBL] [Abstract][Full Text] [Related]
23. A Novel Mutation in the FECH Gene in a Czech Family with Erythropoietic Protoporphyria and a Population Study of IVS3-48C Variant Contributing to the Disease.
Farrag MS; Kučerová J; Šlachtová L; Šeda O; Šperl J; Martásek P
Folia Biol (Praha); 2015; 61(6):227-32. PubMed ID: 26789144
[TBL] [Abstract][Full Text] [Related]
24. Inheritance in erythropoietic protoporphyria: a common wild-type ferrochelatase allelic variant with low expression accounts for clinical manifestation.
Gouya L; Puy H; Lamoril J; Da Silva V; Grandchamp B; Nordmann Y; Deybach JC
Blood; 1999 Mar; 93(6):2105-10. PubMed ID: 10068685
[TBL] [Abstract][Full Text] [Related]
25. A novel mutation in the ferrochelatase gene associated with erythropoietic protoporphyria.
Imoto S; Tanizawa Y; Sato Y; Kaku K; Oka Y
Br J Haematol; 1996 Jul; 94(1):191-7. PubMed ID: 8757534
[TBL] [Abstract][Full Text] [Related]
26. X-linked dominant protoporphyria: The first reported Japanese case.
Ninomiya Y; Kokunai Y; Tanizaki H; Akasaka E; Nakano H; Moriwaki S
J Dermatol; 2016 Apr; 43(4):414-8. PubMed ID: 26387792
[TBL] [Abstract][Full Text] [Related]
27. Human erythropoietic protoporphyria: two point mutations in the ferrochelatase gene.
Lamoril J; Boulechfar S; de Verneuil H; Grandchamp B; Nordmann Y; Deybach JC
Biochem Biophys Res Commun; 1991 Dec; 181(2):594-9. PubMed ID: 1755842
[TBL] [Abstract][Full Text] [Related]
28. A 10376 bp deletion of FECH gene responsible for erythropoietic protoporphyria.
Di Pierro E; Brancaleoni V; Besana V; Ausenda S; Drury S; Cappellini MD
Blood Cells Mol Dis; 2008; 40(2):233-6. PubMed ID: 17888693
[TBL] [Abstract][Full Text] [Related]
29. Heterogeneity of mutations in the ferrochelatase gene in Italian patients with erythropoietic protoporphyria.
Aurizi C; Schneider-Yin X; Sorge F; Macrì A; Minder EI; Biolcati G
Mol Genet Metab; 2007 Apr; 90(4):402-7. PubMed ID: 17196862
[TBL] [Abstract][Full Text] [Related]
30. Autosomal recessive erythropoietic protoporphyria: a syndrome of severe photosensitivity and liver failure.
Sarkany RP; Cox TM
QJM; 1995 Aug; 88(8):541-9. PubMed ID: 7648240
[TBL] [Abstract][Full Text] [Related]
31. Examination of ferrochelatase mutations that cause erythropoietic protoporphyria.
Sellers VM; Dailey TA; Dailey HA
Blood; 1998 May; 91(10):3980-5. PubMed ID: 9573038
[TBL] [Abstract][Full Text] [Related]
32. Novel null-allele mutations and genotype-phenotype correlation in Argentinean patients with erythropoietic protoporphyria.
Parera VE; Koole RH; Minderman G; Edixhoven A; Rossetti MV; Batlle A; de Rooij FW
Mol Med; 2009; 15(11-12):425-31. PubMed ID: 19693296
[TBL] [Abstract][Full Text] [Related]
33. Molecular defect in human erythropoietic protoporphyria with fatal liver failure.
Nakahashi Y; Miyazaki H; Kadota Y; Naitoh Y; Inoue K; Yamamoto M; Hayashi N; Taketani S
Hum Genet; 1993 May; 91(4):303-6. PubMed ID: 8500787
[TBL] [Abstract][Full Text] [Related]
34. Incomplete erythropoietic protoporphyria caused by a splice site modulator homozygous IVS3-48C polymorphism in the ferrochelatase gene.
Mizawa M; Makino T; Nakano H; Sawamura D; Shimizu T
Br J Dermatol; 2016 Jan; 174(1):172-5. PubMed ID: 26280465
[TBL] [Abstract][Full Text] [Related]
35. Antisense oligonucleotide-based therapy in human erythropoietic protoporphyria.
Oustric V; Manceau H; Ducamp S; Soaid R; Karim Z; Schmitt C; Mirmiran A; Peoc'h K; Grandchamp B; Beaumont C; Lyoumi S; Moreau-Gaudry F; Guyonnet-Dupérat V; de Verneuil H; Marie J; Puy H; Deybach JC; Gouya L
Am J Hum Genet; 2014 Apr; 94(4):611-7. PubMed ID: 24680888
[TBL] [Abstract][Full Text] [Related]
36. Genetic analysis of the ferrochelatase gene in eight Japanese patients from seven families with erythropoietic protoporphyria.
Saruwatari H; Ueki Y; Yotsumoto S; Shimada T; Fukumaru S; Kanekura T; Kanzaki T
J Dermatol; 2006 Sep; 33(9):603-8. PubMed ID: 16958804
[TBL] [Abstract][Full Text] [Related]
37. Late-onset erythropoietic porphyria caused by a chromosome 18q deletion in erythroid cells.
Aplin C; Whatley SD; Thompson P; Hoy T; Fisher P; Singer C; Lovell CR; Elder GH
J Invest Dermatol; 2001 Dec; 117(6):1647-9. PubMed ID: 11886534
[TBL] [Abstract][Full Text] [Related]
38. A "null allele" mutation is responsible for erythropoietic protoporphyria in an Israeli patient who underwent liver transplantation: relationships among biochemical, clinical, and genetic parameters.
Schoenfeld N; Mamet R; Minder EI; Schneider-Yin X
Blood Cells Mol Dis; 2003; 30(3):298-301. PubMed ID: 12737948
[TBL] [Abstract][Full Text] [Related]
39. An exon 10 deletion in the mouse ferrochelatase gene has a dominant-negative effect and causes mild protoporphyria.
Magness ST; Maeda N; Brenner DA
Blood; 2002 Aug; 100(4):1470-7. PubMed ID: 12149233
[TBL] [Abstract][Full Text] [Related]
40. Ferrochelatase gene mutations in erythropoietic protoporphyria: focus on liver disease.
Chen FP; Risheg H; Liu Y; Bloomer J
Cell Mol Biol (Noisy-le-grand); 2002 Feb; 48(1):83-9. PubMed ID: 11929052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
